1. [Autoimmune polyendocrinopathy and chronic mucocutaneous candidiasis].
- Author
-
Proto G, Leoni S, Torossi I, Mazzolini A, Grimaldi F, and Bertolissi F
- Subjects
- Addison Disease diagnosis, Addison Disease drug therapy, Adolescent, Calcitriol therapeutic use, Candidiasis, Chronic Mucocutaneous drug therapy, Cortisone analogs & derivatives, Cortisone therapeutic use, Drug Therapy, Combination, Female, Fluconazole therapeutic use, Fludrocortisone therapeutic use, Humans, Hypoparathyroidism diagnosis, Hypoparathyroidism drug therapy, Polyendocrinopathies, Autoimmune drug therapy, Candidiasis, Chronic Mucocutaneous diagnosis, Polyendocrinopathies, Autoimmune diagnosis
- Abstract
A chronic mucocutaneous infection due to yeasts to the Candida genus can be part of the autoimmune polyglandular syndrome, described as APECS, APECED, SPA type I, CES. The authors describe the case of a young patient affected by mucocutaneous candidiasis, hypoparathyroidism and adrenal insufficiency. Chronic mucocutaneous candidiasis was diagnosed first in early childhood and was followed by the development of hypoparathyroidism (4 yrs) and adrenal insufficiency (5 yrs). The initial lesion of this syndrome is still unknown as the reason of the marked susceptibility to mucocutaneous candidiasis without systemic candidiasis. The treatment of mucocutaneous candidiasis has been improved by the introduction of orally active antifungal drugs as Ketoconazole, first, and fluconazole now.
- Published
- 1992